Ospedale San Giovanni Bosco

Turin, Piedmont 10154

1 studies enrolling now · 3 studies all time

What they study most

IgG4 Related Disease, Primary IgA Nephropathy, Primary Membranous Nephropathy

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression — Recruiting now
• A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy — Running, not enrolling
• A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease — Running, not enrolling